AdvaMed Privacy Comments Will Seek Clarity On PHI Disclosure Procedure
This article was originally published in The Gray Sheet
Executive Summary
HHS should clarify whether or not protected health information can be released to foreign governments without the permission of FDA under HIPAA privacy guidelines, AdvaMed says
You may also be interested in...
HHS Reaffirms “Business Associate” Category In HIPAA Final Rule
HHS dismisses suggestions to form a limited subsection of the "business associate" category for certain entities in the agency's final rule implementing the Health Insurance Portability & Accountability Act
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.